Sanofi (SNY) Revenue (2009 - 2026)

Sanofi has disclosed Revenue across 18 years of filings, most recently posting $12.3 billion for Q1 2026.

• Revenue for Q1 2026 came in at $12.3 billion, up 18.21% year-over-year; the trailing twelve-month figure through Mar 2026 was $51.4 billion (up 26.04% YoY), and the FY2025 annual result was $50.8 billion, up 15.68% from the prior year.
• Revenue came in at $12.3 billion for Q1 2026 at Sanofi, up from -$10.0 billion in the prior quarter.
• In the past five years, Revenue ranged from a high of $46.3 billion in Q4 2023 to a low of -$10.0 billion in Q4 2025.
• The 5-year median for Revenue is $10.9 billion (2022), against an average of $13.4 billion.
• Across the five-year window, Revenue soared 323.51% in 2023 and slumped 245.37% in 2025, its largest moves.
• Sanofi's Revenue stood at $10.9 billion in 2022, then jumped by 323.51% to $46.3 billion in 2023, then slumped by 85.16% to $6.9 billion in 2024, then plunged by 245.37% to -$10.0 billion in 2025, then jumped by 223.1% to $12.3 billion in 2026.
• The last three Revenue figures came in at $12.3 billion (Q1 2026), -$10.0 billion (Q4 2025), and $37.8 billion (Q3 2025), per Business Quant data.